GXMC
KYNB

Global X Management Company’s Kyntra Bio KYNB Stock Holding History

Global X Management Company’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$110K Buy
70
+20
+40% +$26.1K ﹤0.01% 995
2018
Q1 		$58K Buy
50
+12
+32% +$15.8K ﹤0.01% 1001
2017
Q4 		$45K Buy
38
+9
+31% +$11.3K ﹤0.01% 929
2017
Q3 		$39K Buy
29
+4
+16% +$4.21K ﹤0.01% 961
2017
Q2 		$20K Buy
25
+16
+178% +$11.1K ﹤0.01% 1148
2017
Q1 		$6K Hold
9
– – ﹤0.01% 1166
2016
Q4 		$5K Hold
9
– – ﹤0.01% 1057
2016
Q3 		$5K Hold
9
– – ﹤0.01% 1062
2016
Q2 		$4K Buy
+9
New +$4.12K ﹤0.01% 950

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Global X Management Company's KYNB Position: Q2 2018 in Review

Global X Management Company increased its Kyntra Bio (KYNB) stake by 40% in Q2 2018, buying an estimated $26.1K and bringing the position to 70 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Global X Management Company first reported a position in KYNB in Q2 2016 and has held it in 9 quarters since. 192 funds tracked by Wall St. Rank hold KYNB as of Q2 2018.

  • Global X Management Company held 70 shares of Kyntra Bio worth $110K as of Q2 2018.
  • Global X Management Company bought 20 Kyntra Bio shares in Q2 2018, an estimated $26.1K.
  • Kyntra Bio made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #995 holding.
  • Global X Management Company first reported a position in Kyntra Bio in Q2 2016 and has held it in 9 quarters since.
  • 192 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.